New cancer clinical trial: A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Published on: November 29, 2017 at 10:00AM
Condition:   Metastatic Colorectal Cancer
Interventions:   Biological: CPGJ602;   Biological: Cetuximab
Sponsor:   Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Recruiting
http://ift.tt/2AiIVsJ